(RTTNews) - Celltrion, Inc. (068270.KS), a biopharmaceutical company, reported a decline in net income on Tuesday despite higher third-quarter 2026 sales than the previous year.
Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.